Items where authors include "Lawrie, A."

Number of items: 94.

Article

Lord, J.M., Veenith, T., Sullivan, J. et al. (1020 more authors) (2024) Accelarated immune ageing is associated with COVID-19 disease severity. Immunity & Ageing, 21. 6. ISSN 1742-4933

Ulrich, A. orcid.org/0000-0003-3280-9974, Wu, Y., Draisma, H. orcid.org/0000-0001-6279-0368 et al. (23 more authors) (2024) Blood DNA methylation profiling identifies cathepsin Z dysregulation in pulmonary arterial hypertension. Nature Communications, 15 (1). 330. ISSN 2041-1723

Kiely, D.G. orcid.org/0000-0003-0184-6502, Hamilton, N., Wood, S. et al. (9 more authors) (2024) Risk assessment and real-world outcomes in chronic thromboembolic pulmonary hypertension: insights from a UK pulmonary hypertension referral service. BMJ Open, 14 (1). e080068. ISSN 2044-6055

Taquet, M., Skorniewska, Z., Zetterberg, H. orcid.org/0000-0003-3930-4354 et al. (1262 more authors) (2023) Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury. Brain Communications, 6 (1). fcad357. ISSN 2632-1297

Gupta, V., Kariotis, S. orcid.org/0000-0001-9993-6017, Rajab, M.D. orcid.org/0000-0002-7591-6203 et al. (15 more authors) (2023) Unsupervised machine learning to investigate trajectory patterns of COVID-19 symptoms and physical activity measured via the MyHeart Counts App and smart devices. npj Digital Medicine, 6. 239. ISSN 2398-6352

Elneima, O. orcid.org/0000-0003-2480-8840, McAuley, H.J.C. orcid.org/0000-0001-8997-0764, Leavy, O.C. et al. (1398 more authors) (2023) Cohort profile: post-hospitalisation COVID-19 (PHOSP-COVID) study. International Journal of Epidemiology. ISSN 0300-5771

Brightling, C.E., Evans, R.A., Singapuri, A. et al. (1049 more authors) (2023) Long COVID research: an update from the PHOSP-COVID Scientific Summit. The Lancet Respiratory Medicine, 11 (11). e93-e94. ISSN 2213-2600

Raman, B., McCracken, C., Cassar, M.P. et al. (1038 more authors) (2023) Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study. The Lancet Respiratory Medicine, 11 (11). pp. 1003-1019. ISSN 2213-2600

Khassafi, F., Chelladurai, P. orcid.org/0000-0002-8258-5115, Valasarajan, C. et al. (23 more authors) (2023) Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension. Nature Cardiovascular Research, 2. pp. 917-936. ISSN 2731-0590

Saunders, L.C. orcid.org/0000-0002-1080-9861, Collier, G.J., Chan, H.-F. orcid.org/0000-0002-5382-2097 et al. (41 more authors) (2023) Longitudinal lung function assessment of patients hospitalised with COVID-19 using 1H and 129Xe lung MRI. Chest, 164 (3). pp. 700-716. ISSN 0012-3692

Jackson, C., Stewart, I.D., Plekhanova, T. et al. (1082 more authors) (2023) Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study. The Lancet Respiratory Medicine, 11 (8). pp. 673-684. ISSN 2213-2600

Zheng, B., Vivaldi, G. orcid.org/0000-0003-0816-9276, Daines, L. orcid.org/0000-0003-0564-4000 et al. (1040 more authors) (2023) Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls. The Lancet Regional Health - Europe, 29. 100635. ISSN 2666-7762

Kheyfets, V.O., Sweatt, A.J., Gomberg-Maitland, M. et al. (7 more authors) (2023) Computational platform for doctor–artificial intelligence cooperation in pulmonary arterial hypertension prognostication: a pilot study. ERJ Open Research, 9 (1). 00484-2022. ISSN 2312-0541

Liew, F. orcid.org/0000-0002-8736-9198, Talwar, S., Cross, A. et al. (1439 more authors) (2023) SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination. eBioMedicine, 87. 104402. ISSN 2352-3964

Lawrie, A., Hamilton, N., Wood, S. et al. (8 more authors) (2022) Healthcare resource utilization and quality of life in patients with sarcoidosis‐associated pulmonary hypertension. Pulmonary Circulation, 12 (4). e12136. ISSN 2045-8940

Majeed, R.W., Wilkins, M.R., Howard, L. et al. (37 more authors) (2022) Pulmonary Vascular Research Institute GoDeep: a meta-registry merging deep phenotyping datafrom international PH reference centers. Pulmonary Circulation, 12 (3). e12123. ISSN 2045-8940

Goh, Z.M., Balasubramanian, N., Alabed, S. orcid.org/0000-0002-9960-7587 et al. (16 more authors) (2022) Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response. Heart, 108. pp. 1392-1400. ISSN 1355-6037

Jones, R.J., De Bie, E.M.D.D., Groves, E. et al. (31 more authors) (2022) Autoimmunity Is a Significant Feature of Idiopathic Pulmonary Arterial Hypertension. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 206 (1). pp. 81-93. ISSN 1073-449X

Hough, R., Lopes, A., Patrick, P. et al. (14 more authors) (2022) Primary graft failure, but not relapse, may be identified by early chimerism following double cord blood unit transplantation. Blood Advances, 6 (7). pp. 2414-2426. ISSN 2473-9529

Alandejani, F., Alabed, S. orcid.org/0000-0002-9960-7587, Garg, P. et al. (23 more authors) (2022) Training and clinical testing of artificial intelligence derived right atrial cardiovascular magnetic resonance measurements. Journal of Cardiovascular Magnetic Resonance, 24 (1). 25.

Dowey, R., Cole, J., Roger Thompson, A.A. et al. (11 more authors) (2022) Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the protein kinase C inhibitor ruboxistaurin. ERJ Open Research, 8 (2). 00596-2021. ISSN 2312-0541

Alkhanfar, D., Shahin, Y. orcid.org/0000-0001-7425-7798, Alandejani, F. et al. (13 more authors) (2022) Severe pulmonary hypertension associated with lung disease is characterised by a loss of small pulmonary vessels on quantitative CT. ERJ Open Research, 8 (2). 00503-2021. ISSN 2312-0541

Alandejani, F., Hameed, A., Tubman, E. et al. (20 more authors) (2022) Imaging and risk stratification in pulmonary arterial hypertension : time to include right ventricular assessment. Frontiers in Cardiovascular Medicine, 9. 797561.

Turton, H.A., Pickworth, J., Paterson, G.G. et al. (3 more authors) (2022) Soluble P-selectin and von Willebrand factor rise in healthy volunteers following non-exertional ascent to high altitude. Frontiers in Physiology, 13. 825819.

Bowley, G., Kugler, E. orcid.org/0000-0003-2536-6140, Wilkinson, R. et al. (6 more authors) (2022) Zebrafish as a tractable model of human cardiovascular disease. British Journal of Pharmacology, 179 (5). pp. 900-917. ISSN 0007-1188

Swift, A.J. orcid.org/0000-0002-8772-409X, Wilson, F., Cogliano, M. et al. (20 more authors) (2021) Repeatability and sensitivity to change of non-invasive end points in PAH: the RESPIRE study. Thorax, 76 (10). pp. 1032-1035. ISSN 0040-6376

Errington, N. orcid.org/0000-0001-6768-7394, Iremonger, J., Pickworth, J.A. orcid.org/0000-0002-7199-364X et al. (13 more authors) (2021) A diagnostic miRNA signature for pulmonary arterial hypertension using a consensus machine learning approach. EBioMedicine, 69. 103444. ISSN 2352-3964

Goh, Z.M., Alabed, S. orcid.org/0000-0002-9960-7587, Shahin, Y. orcid.org/0000-0001-7425-7798 et al. (13 more authors) (2021) Right ventricular adaptation assessed using cardiac magnetic resonance predicts survival in pulmonary arterial hypertension. JACC: Cardiovascular Imaging, 14 (6). pp. 1271-1272. ISSN 1936-878X

Zhu, N., Swietlik, E.M., Welch, C.L. et al. (22 more authors) (2021) Rare variant analysis of 4241 pulmonary arterial hypertension cases from an international consortium implicates FBLN2, PDGFD, and rare de novo variants in PAH. Genome Medicine, 13 (1). p. 80. ISSN 1756-994X

Swift, A.J. orcid.org/0000-0002-8772-409X, Lu, H. orcid.org/0000-0002-0349-2181, Uthoff, J. et al. (11 more authors) (2021) A machine learning cardiac magnetic resonance approach to extract disease features and automate pulmonary arterial hypertension diagnosis. European Heart Journal - Cardiovascular Imaging, 22 (2). pp. 236-245. ISSN 2047-2404

Zawia, A., Arnold, N.D. orcid.org/0000-0002-4317-5738, West, L. orcid.org/0000-0003-2953-2521 et al. (9 more authors) (2021) Altered macrophage polarization induces experimental pulmonary hypertension and is observed in patients with pulmonary arterial hypertension. Arteriosclerosis, thrombosis, and vascular biology, 41 (1). pp. 430-445. ISSN 1079-5642

Lewis, R.A., Billings, C.G., Hurdman, J.A. et al. (17 more authors) (2021) Maximal exercise testing using the incremental shuttle walking test can be used to risk stratify patients with pulmonary arterial hypertension. Annals of the American Thoracic Society, 18 (1). pp. 34-43. ISSN 2329-6933

Ulrich, A., Otero-Núñez, P., Wharton, J. et al. (8 more authors) (2020) Expression quantitative trait locus mapping in pulmonary arterial hypertension. Genes, 11 (11). 1247.

Rhodes, C.J., Otero-Núñez, P., Wharton, J. et al. (28 more authors) (2020) Whole blood RNA profiles associated with pulmonary arterial hypertension and clinical outcome. American Journal of Respiratory and Critical Care Medicine, 202 (4). pp. 586-594. ISSN 1073-449X

Sofianopoulou, E., Church, C., Coghlan, G. et al. (9 more authors) (2020) Deprivation and prognosis in patients with pulmonary arterial hypertension: missing the effect of deprivation on a rare disease? European Respiratory Journal, 56 (2). 1902334. ISSN 0903-1936

Thompson, A.A.R. orcid.org/0000-0002-0717-4551, Wilkins, M.R., Wild, J.M. orcid.org/0000-0002-7246-8660 et al. (2 more authors) (2020) Editorial : pulmonary hypertension : mechanisms and management, history and future. Frontiers in Medicine, 7. 125.

Lewis, R.A., Johns, C.S. orcid.org/0000-0003-3724-0430, Cogliano, M. et al. (20 more authors) (2020) Identification of cardiac MRI thresholds for risk stratification in pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine, 201 (4). pp. 458-468. ISSN 1073-449X

Bellantuono, I. orcid.org/0000-0001-9994-6987, de Cabo, R., Ehninger, D. et al. (9 more authors) (2020) A toolbox for the longitudinal assessment of healthspan in aging mice. Nature Protocols, 15 (2). pp. 540-574. ISSN 1754-2189

Tual-Chalot, S., Garcia-Collado, M., Redgrave, R.E. et al. (10 more authors) (2020) Loss of endothelial endoglin promotes high-output heart failure through peripheral arteriovenous shunting driven by VEGF signaling. Circulation Research, 126 (2). pp. 243-257. ISSN 0009-7330

Kiely, D.G. orcid.org/0000-0003-0184-6502, Lawrie, A. orcid.org/0000-0003-4192-9505 and Humbert, M. (2019) Screening strategies for pulmonary arterial hypertension. European Heart Journal Supplements, 21 (Supplement_K). K9-K20. ISSN 1520-765X

Arnold, N.D. orcid.org/0000-0002-4317-5738, Pickworth, J.A. orcid.org/0000-0002-7199-364X, West, L.E. et al. (24 more authors) (2019) A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension. Nature Communications, 10 (1). 5183. ISSN 2041-1723

Kiely, D.G., Doyle, O., Drage, E. et al. (8 more authors) (2019) Utilising artificial intelligence to determine patients at risk of a rare disease : idiopathic pulmonary arterial hypertension. Pulmonary Circulation, 9 (4). ISSN 2045-8932

Sofianopoulou, E., Kaptoge, S., Gräf, S. et al. (30 more authors) (2019) Traffic exposures, air pollution and outcomes in pulmonary arterial hypertension: A United Kingdom cohort study analysis. European Respiratory Journal, 53 (5). 1801429. ISSN 0903-1936

Billings, C.G., Lewis, R., Hurdman, J.A. et al. (12 more authors) (2019) Express: The incremental shuttle walk test predicts mortality in non-group 1 pulmonary hypertension: results from the ASPIRE Registry. Pulmonary Circulation, 9 (2). ISSN 2045-8932

Sweatt, A.J., Hedlin, H.K., Balasubramanian, V. et al. (11 more authors) (2019) Discovery of distinct immune phenotypes using machine learning in pulmonary arterial hypertension. Circulation Research, 124 (6). pp. 904-919. ISSN 0009-7330

Rhodes, C.J., Batai, K., Bleda, M. et al. (118 more authors) (2019) Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis. Lancet Respiratory Medicine, 7 (3). pp. 227-238. ISSN 2213-2600

Boehm, M., Arnold, N., Braithwaite, A. et al. (11 more authors) (2018) Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension. BMC Pulmonary Medicine, 18. 41. ISSN 1471-2466

Bergemann, R., Allsopp, J., Jenner, H. et al. (8 more authors) (2018) High levels of healthcare utilization prior to diagnosis in idiopathic pulmonary arterial hypertension support the feasibility of an early diagnosis algorithm: the SPHInX project. Pulmonary Circulation, 8 (4). pp. 1-9. ISSN 2045-8940

Bohnen, M.S., Ma, L., Zhu, N. et al. (47 more authors) (2018) Loss-of-function ABCC8 mutations in pulmonary arterial hypertension. Circulation: Genomic and Precision Medicine, 11 (10). e002087. ISSN 2574-8300

Quadery, S.R., Swift, A.J., Billings, C. et al. (23 more authors) (2018) The impact of patient choice on survival in chronic thromboembolic pulmonary hypertension. European Respiratory Journal , 52 (3). 1800589. ISSN 0903-1936

Farkas, D., Thompson, A.A.R. orcid.org/0000-0002-0717-4551, Bhagwani, A.R. et al. (14 more authors) (2018) Toll-like receptor 3 is a therapeutic target for pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine. ISSN 1073-449X

Ramakrishnan, L., Pedersen, S.L., Toe, Q.K. et al. (8 more authors) (2018) The Hepcidin/Ferroportin axis modulates proliferation of pulmonary artery smooth muscle cells. Scientific Reports, 8. 12972. ISSN 2045-2322

Braithwaite, A.T. orcid.org/0000-0003-3228-2172, Marriott, H. and Lawrie, A. (2018) Divergent Roles for TRAIL in Lung Diseases. Frontiers in Medicine, 5. 212. ISSN 2296-858X

Billings, C.G., Lewis, R., Armstrong, I.J. et al. (10 more authors) (2018) Incremental Shuttle Walking Test Distance Is Reduced in Patients With Pulmonary Hypertension in World Health Organisation Functional Class I. Frontiers in Medicine, 5. 172. ISSN 2296-858X

Hickey, P.M. orcid.org/0000-0002-4683-7696, Lawrie, A. orcid.org/0000-0003-4192-9505 and Condliffe, R. (2018) Circulating protein biomarkers in systemic sclerosis related pulmonary arterial hypertension: a review of published data. Frontiers in Medicine, 5. 175. ISSN 2296-858X

Graf, S., Haimel, M., Bleda, M. et al. (62 more authors) (2018) Identification of rare sequence variation underlying heritable pulmonary arterial hypertension. Nature Communications, 9. 1416. ISSN 2041-1723

Chen, K.-H., Dasgupta, A., Lin, J. et al. (13 more authors) (2018) Epigenetic Dysregulation of the Drp1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension: Mechanistic and Therapeutic Implications. Circulation, 117. 031258. ISSN 0009-7322

Renshall, L.J., Arnold, N.D. orcid.org/0000-0002-4317-5738, West, L. et al. (10 more authors) (2018) Selective improvement of pulmonary arterial hypertension with a dual ETA/ETB receptors antagonist in the apolipoprotein E−/− model of PAH and atherosclerosis. Pulmonary Circulation , 8 (1). pp. 1-11. ISSN 2045-8932

Zhang, H.-D., Lv, Z.-C., Wang, L.-T. et al. (7 more authors) (2017) Prognostic significance of reduced blood pressure response to exercise in pediatric pulmonary arterial hypertension. American Journal of Respiratory and Critical Care Medicine, 196 (11). ISSN 1073-449X

Hadinnapola, C., Bleda, M., Haimel, M. et al. (41 more authors) (2017) Phenotypic characterisation of EIF2AK4 mutation carriers in a large cohort of patients diagnosed clinically with pulmonary arterial hypertension. Circulation, 136 (21). pp. 2022-2033. ISSN 0009-7322

Pickworth, J.A. orcid.org/0000-0002-7199-364X, Rothman, A., Iremonger, J. et al. (9 more authors) (2017) EXPRESS: Differential IL-1 signalling induced by BMPR2 deficiency drives pulmonary vascular remodelling. Pulmonary Circulation , 7 (4). pp. 768-776. ISSN 2045-8932

Rhodes, C.J., Wharton, J., Ghataorhe, P. et al. (16 more authors) (2017) Plasma proteome analysis in patients with pulmonary arterial hypertension: an observational cohort study. The Lancet Respiratory Medicine, 5 (9). pp. 717-726. ISSN 2213-2600

Swift, A.J., Capener, D., Johns, C. orcid.org/0000-0003-3724-0430 et al. (10 more authors) (2017) Magnetic Resonance Imaging in the Prognostic Evaluation of Patients with Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine, 196 (2). ISSN 1073-449X

Billings, C.G., Hurdman, J.A., Condliffe, R.A. et al. (13 more authors) (2017) Incremental Shuttle Walking Test Distance and Autonomic Dysfunction Predict Survival in Pulmonary Arterial Hypertension. The Journal of Heart and Lung Transplantation. ISSN 1053-2498

Thompson, A.A.R. orcid.org/0000-0002-0717-4551, Dickinson, R.S., Murphy, F. et al. (32 more authors) (2017) Hypoxia determines survival outcomes of bacterial infection through HIF-1α-dependent reprogramming of leukocyte metabolism. Science Immunology, 2 (8). ISSN 2470-9468

Boehm, M., Lawrie, A. orcid.org/0000-0003-4192-9505, Wilhelm, J. et al. (6 more authors) (2017) Maintained right ventricular pressure overload induces ventricular-arterial decoupling in mice. Experimental Physiology, 102 (2). pp. 180-189. ISSN 0958-0670

Rhodes, C.J., Ghataorhe, P., Wharton, J. et al. (18 more authors) (2017) Plasma Metabolomics Implicate Modified Transfer RNAs and Altered Bioenergetics in the Outcome of Pulmonary Arterial Hypertension. Circulation, 135 (5). pp. 460-475. ISSN 0009-7322

Dawson, S. and Lawrie, A. orcid.org/0000-0003-4192-9505 (2017) From bones to blood pressure, developing novel biologic approaches targeting the osteoprotegein pathway for pulmonary vascular disease. Pharmacol Ther, 169. pp. 78-82.

Thompson, A.A.R. orcid.org/0000-0002-0717-4551 and Lawrie, A. orcid.org/0000-0003-4192-9505 (2017) Targeting Vascular Remodeling to Treat Pulmonary Arterial Hypertension. Trends in Molecular Medicine, 23 (1). pp. 31-45. ISSN 1471-4914

Rothman, A.M., Rowlands, D.J. and Lawrie, A. orcid.org/0000-0003-4192-9505 (2016) miRNA-140-5p: new avenue for pulmonary arterial hypertension drug development? Epigenomics. ISSN 1750-1911

Rothman, A.M. orcid.org/0000-0002-7847-4500, Arnold, N., Pickworth, J. et al. (10 more authors) (2016) MicroRNA-140-5p and SMURF1 Regulate Pulmonary Arterial Hypertension. Journal of Clinical Investigation, 126 (7). pp. 2495-2508. ISSN 1558-8238

Rothman, A., Arnold, N., Pickworth, J. et al. (9 more authors) (2016) MicroRNA-140-5p and SMURF1 regulate pulmonary arterial hypertension. Clinical Investigation. ISSN 2041-6792

Luong, L., Duckles, H., Schenkel, T. et al. (20 more authors) (2016) Heart rate reduction with ivabradine promotes shear stress-dependent anti-inflammatory mechanisms in arteries. Thrombosis and Haemostasis, 116 (1). pp. 181-190. ISSN 0340-6245

Rothman, A.M.K. orcid.org/0000-0002-7847-4500, Arnold, N.D., Chang, W. et al. (8 more authors) (2015) Pulmonary Artery Denervation Reduces Pulmonary Artery Pressure and Induces Histological Changes in an Acute Porcine Model of Pulmonary Hypertension. CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 8. e002569. ISSN 1941-7640

Spiekerkoetter, E., Sung, Y.K., Sudheendra, D. et al. (11 more authors) (2015) Low-Dose FK506 (Tacrolimus) in End-Stage Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine, 192 (2). 254 - 257. ISSN 1073-449X

McCullagh, B.N., Costello, C.M., Li, L. et al. (9 more authors) (2015) Elevated plasma CXCL12 alpha is associated with a poorer prognosis in pulmonary arterial hypertension. PLoS ONE, 10 (4). e0123709. ISSN 1932-6203

Pérez de Ciriza, C., Lawrie, A. and Varo, N. (2015) Osteoprotegerin in cardiometabolic disorders. International Journal of Endocrinology and Metabolism, 2015. 564934. ISSN 1726-9148

Dawson, S., Arnold, N., Pickworth, J. et al. (2 more authors) (2014) TRAIL Deficient Mice Are Protected from Sugen/Hypoxia Induced Pulmonary Arterial Hypertension. Diseases, 2 (3). pp. 260-273. ISSN 2079-9721

Watson, O., Novodvorsky, P., Gray, C. et al. (8 more authors) (2013) Blood flow suppresses vascular Notch signalling via dll4 and is required for angiogenesis in response to hypoxic signalling. Cardiovascular Research, 100 (2). 252 - 261. ISSN 0008-6363

Hameed, A., Bennett, E., Ciani, B. et al. (5 more authors) (2013) No evidence for cardiac dysfunction in Kif6 mutant mice. PLoS One, 8 (1). ISSN 1932-6203

Hameed, A.G., Arnold, N.D., Chamberlain, J. et al. (12 more authors) (2012) Inhibition of tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) reverses experimental pulmonary hypertension. The Journal of Experimental Medicine, 209 (11). 1919 - 1935. ISSN 0022-1007

McGrath, E.E., Lawrie, A., Marriott, H.M. et al. (11 more authors) (2012) Deficiency of tumour necrosis factor-related apoptosis-inducing ligand exacerbates lung injury and fibrosis. Thorax, 67 (9). 796 - 803. ISSN 0040-6376

Condliffe, R., Pickworth, J. orcid.org/0000-0002-7199-364X, Hopkinson, K. et al. (14 more authors) (2012) Serum osteoprotegerin is increased and predicts survival in idiopathic pulmonary arterial hypertension. Pulmonary circulation, 2 (1). pp. 21-27. ISSN 2045-8932

Lawrie, A., Hameed, A.G., Chamberlain, J. et al. (7 more authors) (2011) Paigen diet-fed apolipoprotein E knockout mice develop severe pulmonary hypertension in an interleukin-1-dependent manner. American Journal of Pathology, 179 (4). pp. 1693-1705. ISSN 0002-9440

McGrath, E. E., Marriott, H. M., Lawrie, A. et al. (5 more authors) (2011) TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. Journal of Leukocyte Biology, 90 (5). pp. 855-65. ISSN 1938-3673

Proceedings Paper

Goh, Z.M., Balasubramanian, N., Alabed, S. et al. (16 more authors) (2022) S90 Right ventricular remodelling assessed using cardiac magnetic resonance predicts survival and treatment response in pulmonary arterial hypertension. In: Thorax. British Thoracic Society Winter Meeting 2022, 23-25 Nov 2022, Westminster, London, United Kingdom. BMJ Publishing Group Ltd and British Thoracic Society , a55-a56.

Alandejani, F., Alabed, S. orcid.org/0000-0002-9960-7587, Garg, P. et al. (22 more authors) (2022) Training and clinical validation of artificial intelligence derived right atrial cardiovascular magnetic resonance measurements. In: American Journal of Respiratory and Critical Care Medicine. American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA, 13-18 May 2022, American Thoracic Society 2022 International Conference. American Thoracic Society , a2285-a2285.

Swift, A.J., Lu, H. orcid.org/0000-0002-0349-2181, Garg, P. orcid.org/0000-0002-5483-169X et al. (8 more authors) (2019) 543 A machine-learning CMR approach to extract disease features and automate pulmonary arterial hypertension diagnosis. In: European Heart Journal - Cardiovascular Imaging. EuroCMR 2019, 02-04 May 2019, Venice, Italy. Oxford University Press (OUP) .

Quadery, S.R. orcid.org/0000-0002-9261-010X, Swift, A.J. orcid.org/0000-0002-8772-409X, Billings, C. et al. (21 more authors) (2017) P183 Impact of patient choice on survival in patients with chronic thromboembolic pulmonary hypertension offered pulmonary endarterectomy. In: Thorax. British Thoracic Society Winter Meeting 2017, 06-08 Dec 2017, London, United kingdom. BMJ Publishing Group Ltd and British Thoracic Society , A181.

Rothman, A.M. orcid.org/0000-0002-7847-4500, Arnold, N., Abou Hanna, J. et al. (11 more authors) (2017) Feasibility and safety of a wireless pulmonary artery pressure monitoring system in chronic porcine models of pulmonary hypertension. In: European Heart Journal Supplements. ESC Congress 2017, 26-30 Aug 2017, Barcelona, Spain. Oxford University Press (OUP) .

This list was generated on Sun Apr 14 03:15:19 2024 BST.

Export as	Atom RSS